Yann Godbert
Institut Bergonié · 191 works · 3,094 citations · h-index 23
Top works
- Efficacy of Selpercatinib in RET -Altered Thyroid Cancers
- Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study
- Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer
- Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life Practice
- Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial
- Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase–Rearranged Anaplastic Thyroid Carcinoma
- Identification of a Recurrent STRN/ALK Fusion in Thyroid Carcinomas
- Brain Metastases from Thyroid Carcinoma: A Retrospective Study of 21 Patients
- Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer
- Molecular Pathology of Anaplastic Thyroid Carcinomas: A Retrospective Study of 144 Cases
- A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer
- Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial
- Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study
- Absolute Quantification of Left Ventricular Global and Regional Function at Nuclear MPI Using Ultrafast CZT SPECT: Initial Validation Versus Cardiac MR
- 1913O Results from the registrational phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET mutation-positive medullary thyroid cancer (RET+ MTC)
- Limited efficacy of lenvatinib in heavily pretreated anaplastic thyroid cancer: a French overview
- Over ten years of single-institution experience in percutaneous image-guided treatment of bone metastases from differentiated thyroid cancer
- Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network
- MERAIODE: A Phase II Redifferentiation Trial with Trametinib and 131 I in Metastatic Radioactive Iodine Refractory RAS Mutated Differentiated Thyroid Cancer
- ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial